Journal article
Laryngeal ulceration and hemoptysis secondary to inadvertent alendronate overdose: Case report and review of the literature
Ear, nose, & throat journal, v 91(11), pp 484-485
01 Nov 2012
PMID: 23288794
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Alendronate is commonly used in the treatment of osteoporosis and other bone diseases. Its drug profile includes many recognized side effects, and the literature includes case reports of esophageal irritation and ulceration. However, little has been published about laryngeal effects. We describe the case of a 77-year-old man who presented with hemoptysis secondary to laryngeal ulceration caused by the inadvertent misuse of alendronate. This case highlights the need for otolaryngologists to be familiar with alendronate and its side effects.
Metrics
Details
- Title
- Laryngeal ulceration and hemoptysis secondary to inadvertent alendronate overdose: Case report and review of the literature
- Creators
- John Hanna - Saint Peter's University HospitalJoseph Bee - Southeast Georgia Health SystemRobert T. Sataloff - Drexel University
- Publication Details
- Ear, nose, & throat journal, v 91(11), pp 484-485
- Publisher
- VENDOME GROUP LLC
- Number of pages
- 2
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- College of Medicine
- Web of Science ID
- WOS:000311529600007
- Scopus ID
- 2-s2.0-84871164294
- Other Identifier
- 991019312354304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Otorhinolaryngology